Use of IP Chemotherapy in Ovarian Cancer: The Critical Questions THE GONZALEZ/GREEN/MUGGIA ARTICLE REVIEWED

被引：0
|
作者：
Trimble, Edward L. [1 ]
Fujiwara, Keiichi [2 ]
Marth, Christian [3 ]
Abrams, Jeffrey [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[3] Innsbruck Med Univ Hosp, Innsbruck, Austria
来源：
ONCOLOGY-NEW YORK | 2011年 / 25卷 / 02期
关键词：
INTRAPERITONEAL CHEMOTHERAPY; SURVIVAL; SURGERY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 174
页数：3
相关论文
共 31 条
  • [21] Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer
    Mukherjee, Amrita
    Shammas, Natalie
    Xu, Lanfang
    Cannavale, Kimberly L.
    Gilfillan, Alec D.
    Szamreta, Elizabeth A.
    Monberg, Matthew
    Hodeib, Melissa
    Chao, Chun R.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] RETRACTED: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer (Retracted Article)
    Pedro Antonio, Cascales Campos
    Francisco-Cristobal, Munoz-Casares
    Alida, Gonzalez-Gil
    Susana, Sanchez-Garcia
    Israel, Manzanedo
    Rafael, Morales
    David, Padilla-Valverde
    Pedro, Villarejo
    Fernando, Pereira
    Elena, Gil
    Jose, Gil
    CLINICAL & EXPERIMENTAL METASTASIS, 2021, 38 (02) : 255 - 255
  • [23] The Effect of the APPRISE Mandate on Use of Erythropoiesis-Stimulating Agents and Transfusion Rates in Patients With Ovarian Cancer Receiving Chemotherapy
    Boone, Jonathan D.
    Fauci, Janelle M.
    Walters, Christy L.
    Whitworth, Jenny M.
    Bevis, Kerri S.
    Alvarez, Ronald D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (02) : 367 - 371
  • [24] Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer Brief Report
    Skaznik-Wikiel, Malgorzata E.
    Sukumvanich, Paniti
    Beriwal, Sushil
    Zorn, Kristin K.
    Kelley, Joseph L.
    Richard, Scott D.
    Krivak, Thomas C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 1013 - 1017
  • [25] Treatment of Chemotherapy-Induced Anemia in Ovarian Cancer Patients Does the Use of Erythropoiesis-Stimulating Agents Worsen Survival?
    Rocconi, Rodney P.
    Sullivan, Paula
    Long, Beverly
    Maize, Marie
    Brown, Jennifer
    Arbuckle, Janeen
    Bevis, Kerri
    Estes, Jacob M.
    Reed, Eddie
    Finan, Michael A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 786 - 791
  • [26] The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study
    Manzanedo, I.
    Pereira, F.
    Serrano, A.
    Perez-Viejo, E.
    Martinez-Torres, B.
    Carrion, L.
    Calzas, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (10) : 1357 - 1363
  • [27] Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian CancerA National Cancer Database Study
    Leiserowitz, Gary S.
    Lin, Jeff F.
    Tergas, Ana I.
    Cliby, William A.
    Bristow, Robert E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 675 - 683
  • [28] Malignant epithelial ovarian cancer: Role of intra peritoneal chemotherapy and hyperthermic intra peritoneal chemotherapy (HIPEC): Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa
    Bakrin, N.
    Gladieff, L.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (02): : 214 - 221
  • [29] Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study
    Shim, Seung-Hyuk
    Yang, Eun-Jung
    Jang, Eun Bi
    Lee, Seungjun
    Kim, Hee Seung
    Shin, Yoon-Kyung
    Lee, Shin-Wha
    Chang, Chi-Son
    Song, Heekyoung
    Lee, Sung Jong
    Kim, Jeeyeon
    Chang, Suk-Joon
    Lim, Myong Cheol
    Choi, Chel Hun
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 167 (01) : 132 - 141
  • [30] Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
    Harter, P.
    du Bois, A.
    Mahner, S.
    Pfisterer, J.
    Ortmann, O.
    Marth, C.
    Fink, D.
    Hilpert, F.
    Wagner, U.
    Sehouli, J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (02) : 147 - 149
1234